medigraphic.com

2007, Number 2

<< Back Next >>

Vet Mex 2007; 38 (2)

Epidemiological study in a bovine herd with intermediate prevalence of brucellosis, vaccinated with RB51 and rfbK rough mutant strains of Brucella abortus

Cantú A, Díaz AE, Hernández AL, Adams GL, Suárez GF

Language: English/Spanish
References: 27
Page: 197-206
PDF size: 206.95 Kb.


ABSTRACT

With the objective of analyzing the behavior of two Brucella abortus rough vaccines, a brucellosis infected herd in which the prevalence of the disease was 8.7% was worked with. The animals were randomly distributed in three groups: Group vaccinated with RB51 had 392 cows; Group vaccinated with rfbK had 237 cows, and non-vaccinated Group had 35 cows. Bacteriological and serological studies were performed in those animals for a period of one year and an experimental longitudinal comparative and prospective epidemiological study was carried out. There were abortions and stillborn calves in the three groups, and Brucella abortus biotype 1 was isolated from the milk of two cows in the control group. Using the criteria that animals vaccinated with rough strains, positive to card test, were infected, the rate of monthly incidence for the vaccinated cows with RB51 was 1.65 per each 100. For the cows that were immunized with rfbK this value was of 2.7, with a signifi cant difference between groups (P ‹ 0.001). If the results are analyzed using the criterion by which, animals that present equal or higher titers to 1:100 remain as reactors, and those that have titers of 1:50 or less present a transitory answer becoming negatives, the rate of monthly incidence for the cows vaccinated with RB51 was of 0.21 per each 100 immunized cows. For the cows that were immunized with rfbK this value was of 0.35, not showing a signifi cant difference between groups (P › 0.01). It is concluded that in vaccinated herds with intermediate prevalence of brucellosis, the presence of post-vaccinated reactors is due to a secondary type response to contact with B. abortus fi eld strains, which does not necessarily indicate infection and can be discerned by using the test of Rivanol; under this criterion, both vaccines confer good protection.


REFERENCES

  1. Flores CR, Fernandez CL, Trejo SJ, Del Rio VJ. Adult cattle vaccination with strain 19 reduced doses for the control of brucellosis a fi eld experience in Mexico. Int J Zoon 1985;122:299-303.

  2. Nicoletti P. Prevalence and persistence of Brucella abortus strain 19 infections and prevalence of other biotypes in vaccinated adult dairy cattle. J Am Vet Med Assoc 1981;178:143-145.

  3. Nicoletti P. Vaccination against Brucella. Adv Biotechnol Processes 1990;13:147-168.

  4. Diaz R, Jones LM, Leons D, Wilson JB. Surface antigens of smooth Brucellae. J Bacteriol 1968;96:893-903.

  5. Taylor AW, McDiarmid A. The stability of the avirulent characters of Brucella abortus, strain 19 and strain 45/20 in lactating and pregnant cows. Vet Rec 1949;61:317–318.

  6. Bustamante SJ, Salazar HFI, Díaz AE, Manzano CC, Pérez GR, Hernández AL. Estudio bacteriológico y serológico de brucelosis en vacas revacunadas con dosis reducida de cepa 19 de Brucella abortus. Téc Pec Méx 2000;38:35-42.

  7. Schurig GG, Roop RM, Bagchi SB, Buhrman D, Sricanganathan N. Biological properties of RB51, a stable rough strain of Brucella abortus. Vet Microbiol 1991;28:171-188.

  8. Moriyon UI, Grillo MJ, Monreal D, Gonzalez D, Marin C, Lopez-Goñi I et al. Rough vaccines in animal brucellosis: Structural and genetic basis and present status. Vet Res 2004; 35:1–38.

  9. Secretaría de Agricultura y Desarrollo Rural. Norma Ofi cial Mexicana NOM-041-ZOO-1995. Diario Ofi cial de la Federación (20 agosto). México (DF): SAGAR, 1996.

  10. Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory. Paris (Francia): Institute National de la Recherche Agronomique, 1988.

  11. Farrell ID. The development of a new selective medium for the isolation of Brucella abortus from contaminated sources. Res Vet Sci 1974;16:280–286.

  12. Cheville NF, Stevens GM, Jensen AE, Tatum FM, Halling SM. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of B. abortus. Am J Vet Res 1993;54:1591-1597.

  13. Nielsen K, Gall D, Kelly W, Henning MD, Garcia M. Improved competitive enzyme immunoassay for the diagnosis of bovine brucellosis. Vet Immunol Immunopathol 1995;46:285-291.

  14. Palmer MV, Olsen SC, Cheville NF. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am J Vet Res 1997;58: 472-477.

  15. Samartino LE, Fort M, Gregoret R, Schurig GG. Use of Brucella abortus vaccine strain RB51 in pregnant cows after calfhood vaccination with strain 19 in Argentina. Prev Vet Med 2000;45:193-199

  16. Stevens MG, Olsen S. Antibody response to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51. Infect Immun 1996;64:1030-1034.

  17. Stevens MG, Olsen SC, Palmer MV, Pugh GW. Immune response and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51. Infect Immun, 1996;64:4534-4551.

  18. Uzal FA, Samartino L, Schurig GG, Carrasco A, Nielsen K, Cabrera RF et al. Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle. Vet Res Commun 2000;24:143-151.

  19. Stevens MG, Hennager DC, Olsen SC, Cheville NF. Serological response in diagnostic test for brucellosis in cattle vaccinated with Brucella abortus strain 19 or RB5l. J Clin Microbiol 1994;32:1065-1066.

  20. Elzer PH, Enright FM, Colby L, Hagius SD, Walker JV, Fatemi MB et al. Oral vaccination of cattle with Brucella abortus strain RB51 protects against infection and abortion induced by virulent challenge. Am J Vet Res 1999;59:1575-1578.

  21. Lord VR, Schurig GG, Cherwonogrodsky JW, Marcano MJ, Melendez GE. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res 1998; 59:1016-1020.

  22. Leal-Hernandez M, Diaz-Aparicio E, Perez R, Hernandez L, Arellano-Reynoso B, Edgar Alfonseca et al. Protection of Brucella abortus RB51 vaccine in cows introduced in a herd with active brucellosis. Comp Immunol Microbiol Infect Dis 2005; 28: 63-70.

  23. Díaz A E, Arellano RB , Herrera LE , Leal HM , Suárez GF. Estudio de la respuesta serológica post-vacunal atípica a Brucella abortus RB51, en zonas endémicas de brucelosis. Memorias del XIX Congreso Panamericano de Ciencias Veterinarias. 2004 octubre 24-28; Buenos Aires (Argentina). Buenos Aires (Argentina): Asociación Panamericana de Ciencias Veterinarias, 2004:19

  24. Perea VM, Mora PO. Evaluación de vacunas (Rev 1, RB51 y rfbK) en rebaños caprinos con brucelosis (tesis de licenciatura). Cholula (Puebla) México: Benemérita Universidad Autónoma de Puebla, 2000.

  25. Herrera LE. Comportamiento de la vacuna rugosa RB51 (Brucella abortus) en hatos bovinos con diferente prevalencia de brucelosis (tesis de maestría). México (DF) México: Universidad Nacional Autónoma de México, 2002.

  26. Zambrano AJ, Villava FM, Schurig GG, Cherwonogrodzky J. Preliminary results for the vaccination of pregnant cattle with Brucella abortus strain 19 or B. abortus strain RB51 (Special issue). Arch Med Vet 1995; 27:119-123.

  27. Van Metre DC, Kennedy GA, Olsen SC, Hansen GR, Ewalt DR. Brucellosis induced by RB51 vaccine in a pregnant heifer. J Am Vet Med Assoc 1999;215: 1491-1493.




2020     |     www.medigraphic.com